Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) has enrolled the first patients in its Phase 3 trial for eRapa, an encapsulated form ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE